• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nextcure Inc (NQ: NXTC )

    1.490 -0.080 (-5.10%)
    Streaming Delayed Price Updated: 2:59 PM EDT, Jul 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 15,697
    Open 1.570
    Bid (Size) 1.480 (3)
    Ask (Size) 1.510 (3)
    Prev. Close 1.570
    Today's Range 1.480 - 1.660
    52wk Range 0.9800 - 2.570
    Shares Outstanding 27,973,289
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
    From NextCure
    Via GlobeNewswire
    NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
    From NextCure
    Via GlobeNewswire

    Performance

    YTD
    +29.57%
    +29.57%
    1 Month
    +10.37%
    +10.37%
    3 Month
    -31.02%
    -31.02%
    6 Month
    +24.17%
    +24.17%
    1 Year
    -17.68%
    -17.68%

    More News

    Read More
    NXTC Stock Earnings: NextCure Misses EPS for Q1 2024
    Via InvestorPlace
    NXTC Stock Earnings: NextCure Beats EPS for Q4 2023
    Via InvestorPlace
    NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
    From NextCure
    Via GlobeNewswire
    NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
    From NextCure
    Via GlobeNewswire
    NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
    From NextCure
    Via GlobeNewswire
    NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
    From NextCure
    Via GlobeNewswire
    NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
    From NextCure
    Via GlobeNewswire
    Wall Street’s Favorite Penny Stocks? 7 Names That Could Make You Filthy Rich
    Via InvestorPlace
    Topics Economy
    Exposures Interest Rates
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    NextCure Provides Business Update and Reports Full Year 2023 Financial Results
    From NextCure
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances
    From NextCure
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders
    From NextCure
    Via GlobeNewswire
    NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury
    From NextCure
    Via GlobeNewswire
    Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    US Stocks Higher; Initial Jobless Claims Fall To 202,000
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    NextCure Provides Year-End Clinical Pipeline Updates
    From NextCure
    Via GlobeNewswire
    NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference
    From NextCure
    Via GlobeNewswire
    NextCure Publishes Non-Clinical Data Defining the Mechanism of Action for NC525, a Novel LAIR-1 Antibody for AML
    From NextCure
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.